Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Pediatric Gastroenterology, Hepatology & Nutrition ; : 355-360, 2018.
Artículo en Inglés | WPRIM | ID: wpr-717798

RESUMEN

Recently, fecal microbiota transplantation (FMT) has been attracting attention as a possible medical treatment of ulcerative colitis (UC). A randomized controlled trial of FMT for children with UC is currently underway. Therapeutic effects of FMT for adults with UC remain controversial. We report two cases of early-onset UC in children. A patient was diagnosed with UC at age 1-year 9-month and underwent FMT at age 2-year 3-month. He attained clinical remission for three weeks after FMT, but then relapsed at four weeks, ultimately undergoing a total colectomy. Another child was diagnosed with UC at 2-year 10-month and she underwent FMT at age 5 years. She has remained in clinical remission following FMT for 24 months and her UC has been maintained without complications with tacrolimus and azathioprine. We report that FMT for early-onset UC appears to be safe and potentially effective.


Asunto(s)
Adulto , Niño , Humanos , Azatioprina , Colectomía , Colitis Ulcerosa , Trasplante de Microbiota Fecal , Microbioma Gastrointestinal , Tacrolimus , Usos Terapéuticos , Úlcera
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA